APEX1 and cancer: Many studies have shown that APE1 expression is increased in various malignant tumors, including NSCLC [19], colorectal cancer [20], ovarian cancer [21, 22], glioma [23], cervical cancer [24], prostate cancer [25] and pancreatic cancer [26].